United Therapeutics Corpo... (UTHR)
NASDAQ: UTHR
· Real-Time Price · USD
312.86
0.80 (0.26%)
At close: Aug 15, 2025, 3:59 PM
313.13
0.09%
After-hours: Aug 15, 2025, 05:27 PM EDT
United Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 309.5M | 322.2M | 301.3M | 309.1M | 278.1M | 306.6M | 217.1M | 267.6M | 259.2M | 240.9M | 132.1M | 239.3M | 116M | 239.9M | 112.2M | 162.7M | 172.6M | 28.3M |
Depreciation & Amortization | 21.1M | 19.8M | 19.7M | 19.1M | 18.7M | 15M | 13.7M | 13.3M | 12.9M | 13.3M | 13.2M | 12.9M | 12.7M | 12.5M | 12.6M | 12.4M | 12.4M | 12.5M |
Stock-Based Compensation | 37.8M | 31.8M | 27M | 41.7M | 49.7M | 25.6M | 16.6M | 21.1M | 13.8M | -12.4M | 64.8M | -2.4M | 65.5M | -21.1M | 44.7M | 24.6M | 29.1M | 40.1M |
Other Working Capital | n/a | 134.5M | -37.1M | 42.4M | -136.4M | 75.5M | -41.3M | -4.3M | -78.2M | -2.8M | -94.3M | 29.3M | -130.5M | 44.9M | -12.6M | -18.6M | -71.5M | -10.2M |
Other Non-Cash Items | -176.7M | 9.4M | -2.6M | -5.7M | -2M | -10.5M | -5M | 35.8M | -37.3M | 120.6M | -17.1M | 6.4M | -1.7M | 36.3M | 49.8M | 10.5M | -36.8M | 49M |
Deferred Income Tax | n/a | n/a | n/a | n/a | -3.5M | n/a | n/a | -2.5M | -3.2M | -71M | -62.2M | 61.3M | -58.1M | -12.7M | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 78M | -4.2M | 13M | -108.8M | 39.8M | -91.7M | 10.9M | -139.1M | 83.4M | -2.6M | -58.9M | -7.4M | 33.8M | 14M | -47.5M | -29.4M | 14.1M |
Operating Cash Flow | 191.7M | 461.2M | 341.2M | 377.2M | 232.2M | 376.5M | 150.7M | 346.2M | 106.3M | 374.8M | 128.2M | 258.6M | 127M | 288.7M | 174.6M | 185.6M | 148.2M | 89.8M |
Capital Expenditures | -62.2M | -74.9M | -86.7M | -76.5M | -45.1M | -38.2M | -78.7M | -65.7M | -44.7M | -41.3M | -39.5M | -68.8M | -17M | -13.5M | -70.6M | -23.3M | -16.3M | -10.6M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -89.2M | 237.1M | 178.8M | 179.8M | 8.6M | 23.7M | 152M | 345.7M | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.81B | -692.3M | -478.5M | -407.8M | -231M | -529.3M | -308M | -644.8M | -672M | -889.5M | -430.5M | -270M | -530.5M | -477.6M | -496.9M | -529M | -310.4M | -559M |
Sales Maturities Of Investments | 304.2M | 611.7M | 478M | 387.2M | 196.5M | 1.31B | 526.7M | 407.7M | 493.2M | 709.7M | 268.6M | 246.3M | 378.5M | 131.9M | 371.7M | 308.6M | 285.6M | 563.3M |
Other Investing Acitivies | 1.26B | -9.2M | -36M | -17.8M | -400K | -4.3M | -8.7M | -247.7M | -182.5M | -179.8M | 3.5M | -25.2M | -152M | -345.7M | -125.2M | -212.6M | -32.6M | 4.3M |
Investing Cash Flow | -299.9M | -164.7M | -123.2M | -114.9M | -80M | 735.3M | 42.1M | -313.4M | -227.2M | -221.1M | -189.3M | -94M | -169M | -359.2M | -195.8M | -235.9M | -48.9M | -6.3M |
Debt Repayment | n/a | -100M | -100M | -100M | -100M | -100M | -100M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | -15.3M | -300K | -400K | -11.5M | -1B | -100K | -200K | -13.5M | -13.5M | 11.4M | -300K | n/a | -11.1M | -200K | -200K | -200K | -10.2M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -198.6M | -15.3M | 25.6M | 36.3M | -100K | 32M | 7.3M | 7.8M | 24.7M | 48.6M | 55.5M | 7.3M | 23.9M | 100K | 7.7M | 16.8M | 10.8M | 20.3M |
Financial Cash Flow | -198.6M | -93.8M | -74.7M | -64.1M | -48M | -1.07B | -92.8M | 7.6M | 24.7M | 48.6M | 55.5M | 7M | 23.9M | -11M | 7.5M | 16.6M | 10.6M | 10.1M |
Net Cash Flow | -306.8M | 202.7M | 143.3M | 198.2M | 104.2M | 43.8M | 100M | 40.4M | -96.2M | 202.3M | -5.6M | 171.6M | -18.1M | -81.5M | -13.7M | -33.7M | 109.9M | 93.6M |
Free Cash Flow | 129.5M | 386.3M | 254.5M | 300.7M | 187.1M | 338.3M | 72M | 280.5M | 61.6M | 333.5M | 88.7M | 189.8M | 110M | 275.2M | 104M | 162.3M | 131.9M | 79.2M |